Cargando…

1,25-(OH)(2)D(3) ameliorates renal interstitial fibrosis in UUO rats through the AMPKα/mTOR pathway

OBJECTIVE: To investigate the effects of 1,25(OH)(2)D(3) on renal fibrosis associated with the AMP-activated protein kinase (AMPK)α/mechanistic target of rapamycin (mTOR) signalling pathway in a rat model of unilateral ureteral obstruction (UUO). METHODS: A total of 54 male Sprague Dawley rats were...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Shasha, Yang, Xiaopeng, Wang, Jianwu, Luo, Jing, Guo, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871069/
https://www.ncbi.nlm.nih.gov/pubmed/33530801
http://dx.doi.org/10.1177/0300060520981360
_version_ 1783648940633096192
author Tian, Shasha
Yang, Xiaopeng
Wang, Jianwu
Luo, Jing
Guo, Hui
author_facet Tian, Shasha
Yang, Xiaopeng
Wang, Jianwu
Luo, Jing
Guo, Hui
author_sort Tian, Shasha
collection PubMed
description OBJECTIVE: To investigate the effects of 1,25(OH)(2)D(3) on renal fibrosis associated with the AMP-activated protein kinase (AMPK)α/mechanistic target of rapamycin (mTOR) signalling pathway in a rat model of unilateral ureteral obstruction (UUO). METHODS: A total of 54 male Sprague Dawley rats were randomly divided into three groups: sham-operation group, UUO group, and UUO plus calcitriol (3 ng/100 g) group. Renal tissue was excised for histological examination by immunohistochemistry and Western blot, and for gene expression analysis using real-time polymerase chain reaction. RESULTS: 1,25(OH)(2)D(3) enhanced AMPKα levels, inhibited mTOR levels and slowed the development of interstitial fibrosis in kidney tissue. Compared with the UUO plus calcitriol group, UUO rats demonstrated more severe renal damage characterized by marked tubular atrophy, interstitial fibrosis and significant induction of fibrogenic transforming growth factor-β1 and increased extra-cellular matrix proteins (α-smooth muscle actin and collagen type III), and decreased E-cadherin. CONCLUSION: Treatment with 1,25(OH)(2)D(3) altered the AMPKα/mTOR signalling pathway to suppress excessive fibroblast activation observed in UUO rats. This may serve as a novel mechanism to ameliorate renal dysfunction and fibrotic lesions.
format Online
Article
Text
id pubmed-7871069
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-78710692021-02-19 1,25-(OH)(2)D(3) ameliorates renal interstitial fibrosis in UUO rats through the AMPKα/mTOR pathway Tian, Shasha Yang, Xiaopeng Wang, Jianwu Luo, Jing Guo, Hui J Int Med Res Pre-Clinical Research Report OBJECTIVE: To investigate the effects of 1,25(OH)(2)D(3) on renal fibrosis associated with the AMP-activated protein kinase (AMPK)α/mechanistic target of rapamycin (mTOR) signalling pathway in a rat model of unilateral ureteral obstruction (UUO). METHODS: A total of 54 male Sprague Dawley rats were randomly divided into three groups: sham-operation group, UUO group, and UUO plus calcitriol (3 ng/100 g) group. Renal tissue was excised for histological examination by immunohistochemistry and Western blot, and for gene expression analysis using real-time polymerase chain reaction. RESULTS: 1,25(OH)(2)D(3) enhanced AMPKα levels, inhibited mTOR levels and slowed the development of interstitial fibrosis in kidney tissue. Compared with the UUO plus calcitriol group, UUO rats demonstrated more severe renal damage characterized by marked tubular atrophy, interstitial fibrosis and significant induction of fibrogenic transforming growth factor-β1 and increased extra-cellular matrix proteins (α-smooth muscle actin and collagen type III), and decreased E-cadherin. CONCLUSION: Treatment with 1,25(OH)(2)D(3) altered the AMPKα/mTOR signalling pathway to suppress excessive fibroblast activation observed in UUO rats. This may serve as a novel mechanism to ameliorate renal dysfunction and fibrotic lesions. SAGE Publications 2021-02-02 /pmc/articles/PMC7871069/ /pubmed/33530801 http://dx.doi.org/10.1177/0300060520981360 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Pre-Clinical Research Report
Tian, Shasha
Yang, Xiaopeng
Wang, Jianwu
Luo, Jing
Guo, Hui
1,25-(OH)(2)D(3) ameliorates renal interstitial fibrosis in UUO rats through the AMPKα/mTOR pathway
title 1,25-(OH)(2)D(3) ameliorates renal interstitial fibrosis in UUO rats through the AMPKα/mTOR pathway
title_full 1,25-(OH)(2)D(3) ameliorates renal interstitial fibrosis in UUO rats through the AMPKα/mTOR pathway
title_fullStr 1,25-(OH)(2)D(3) ameliorates renal interstitial fibrosis in UUO rats through the AMPKα/mTOR pathway
title_full_unstemmed 1,25-(OH)(2)D(3) ameliorates renal interstitial fibrosis in UUO rats through the AMPKα/mTOR pathway
title_short 1,25-(OH)(2)D(3) ameliorates renal interstitial fibrosis in UUO rats through the AMPKα/mTOR pathway
title_sort 1,25-(oh)(2)d(3) ameliorates renal interstitial fibrosis in uuo rats through the ampkα/mtor pathway
topic Pre-Clinical Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871069/
https://www.ncbi.nlm.nih.gov/pubmed/33530801
http://dx.doi.org/10.1177/0300060520981360
work_keys_str_mv AT tianshasha 125oh2d3amelioratesrenalinterstitialfibrosisinuuoratsthroughtheampkamtorpathway
AT yangxiaopeng 125oh2d3amelioratesrenalinterstitialfibrosisinuuoratsthroughtheampkamtorpathway
AT wangjianwu 125oh2d3amelioratesrenalinterstitialfibrosisinuuoratsthroughtheampkamtorpathway
AT luojing 125oh2d3amelioratesrenalinterstitialfibrosisinuuoratsthroughtheampkamtorpathway
AT guohui 125oh2d3amelioratesrenalinterstitialfibrosisinuuoratsthroughtheampkamtorpathway